Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Quinolinomorphinans for ischemic, hemorrhagic, traumatic or degenerative brain disorders

Dec. 11, 1998

Wide series of adenosine kinase inhibitors undergoing evaluation at Abbott

Dec. 10, 1998

Toray discloses new epsilon opioid receptor ligands

Dec. 10, 1998

Phase II trial of diabetic neuropathy Rx commenced by Myelos

Dec. 10, 1998

Candidate antidepressants available for licensing from Berkeley Lab

Dec. 9, 1998

Lilly obtains exclusive worldwide rights to (R)-fluoxetine

Dec. 9, 1998

First report of efficacy of oral, sustained-release fampridine in SCI

Dec. 9, 1998

Adenosine kinase inhibitors and methods of use described by Abbott

Dec. 8, 1998

Central muscarinic receptor agonists patented by U. of Toledo

Dec. 7, 1998

Zomig copromoted by Cephalon in the U.K.

Dec. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026